Adeno-associated virus-based gene therapy treats inflammatory kidney disease in mice
September 2024 | New Publication
Wu G et al., J Clin Invest. 2024
This study showcases the potential of AAV as a gene delivery platform for challenging cell types. The development of AAV2-GEC and its successful application in the treatment of antibody-mediated kidney disease represents a significant step forward and opens up promising avenues for kidney medicine.
For further information visit:
JCI - Adeno-associated virus-based gene therapy treats inflammatory kidney disease in mice
More articles in this category
Martinistraße 52
Campus Research N27
20246 Hamburg Germany
